News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
576,683 Results
Type
Article (25575)
Company Profile (226)
Press Release (550972)
Multimedia
Podcasts (247)
Webinars (22)
Section
Business (197179)
Career Advice (1425)
Deals (30615)
Drug Delivery (127)
Drug Development (64764)
Employer Resources (161)
FDA (11758)
Job Trends (11185)
News (282667)
Policy (23187)
Tag
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (1194)
Academic (1)
Accelerated approval (44)
ADA (32)
Adcomms (20)
Allergies (136)
Alliances (39710)
ALS (170)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (421)
Approvals (12094)
Artificial intelligence (618)
ASCO (227)
Autoimmune disease (289)
Automation (48)
Bankruptcy (332)
Best Places to Work (8206)
BIO (81)
Biologics (3)
BIOSECURE Act (18)
Biosimilars (183)
BioSpace Insights (234)
Biotechnology (145)
Bladder cancer (159)
Brain cancer (48)
Breast cancer (598)
Cancer (4732)
Cardiovascular disease (354)
Career advice (1254)
Career pathing (49)
CAR-T (289)
CDC (37)
Celiac Disease (2)
Cell therapy (811)
Cervical cancer (39)
Clinical research (56598)
Collaboration (1805)
Commercialization (8)
Company closure (7)
Compensation (1508)
Complete response letters (82)
COVID-19 (2036)
CRISPR (103)
C-suite (1177)
Cystic fibrosis (116)
Data (6681)
Decentralized trials (2)
Denatured (100)
Depression (154)
Dermatology (68)
Diabetes (461)
Diagnostics (5212)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (310)
Drug pricing (112)
Drug shortages (19)
Duchenne muscular dystrophy (282)
Earnings (81508)
Editorial (64)
Employer branding (22)
Employer resources (136)
Events (100123)
Executive appointments (1017)
FDA (14879)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (23)
Frontotemporal dementia (29)
Funding (1510)
Gene editing (218)
Generative AI (56)
Gene therapy (647)
GLP-1 (775)
Government (2383)
Grass and pollen (3)
Guidances (329)
Healthcare (12007)
Hematology (132)
HIV (68)
Huntington's disease (53)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (91)
Immunology and inflammation (244)
Immuno-oncology (90)
Indications (175)
Infectious disease (2302)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (106)
Intellectual property (301)
Interviews (217)
IPO (14334)
IRA (33)
Job creations (3121)
Job search strategy (1075)
JPM (64)
Kidney cancer (19)
Labor market (126)
Layoffs (428)
Leadership (39)
Legal (6285)
Licensing (10)
Liver cancer (66)
Longevity (33)
Lung cancer (661)
Lymphoma (309)
Machine learning (49)
Management (41)
Manufacturing (950)
Marketing (12)
MASH (188)
Medical device (10050)
Medtech (10222)
Mergers & acquisitions (17462)
Metabolic disorders (1212)
mRNA (234)
Multiple sclerosis (149)
NASH (13)
Neurodegenerative disease (382)
Neuropsychiatric disorders (85)
Neuroscience (2655)
Neurotech (1)
NextGen: Class of 2026 (4448)
Non-profit (1612)
Now hiring (83)
Obesity (512)
Opinion (291)
Ovarian cancer (180)
Pain (213)
Pancreatic cancer (256)
Parkinson's disease (286)
Partnered (35)
Patents (580)
Patient recruitment (636)
Peanut (43)
People (51245)
Pharmaceutical (45)
Pharmacy benefit managers (20)
Phase 1 (18265)
Phase 2 (25522)
Phase 3 (17888)
Pipeline (8834)
Policy (267)
Postmarket research (1753)
Preclinical (7646)
Press Release (57)
Prostate cancer (231)
Psychedelics (70)
Radiopharmaceuticals (275)
Rare diseases (999)
Real estate (4195)
Recruiting (65)
Regulatory (18976)
Reports (82)
Research institute (1217)
Resumes & cover letters (193)
Rett syndrome (44)
RNA editing (23)
RSV (57)
Schizophrenia (159)
Series A (287)
Series B (201)
Service/supplier (6)
Sickle cell disease (96)
Special edition (33)
Spinal muscular atrophy (119)
Sponsored (39)
Startups (3089)
State (2)
Stomach cancer (8)
Supply chain (90)
Tariffs (40)
The Weekly (144)
Vaccines (913)
Venture capital (132)
Weight loss (305)
Women's health (109)
Worklife (21)
Date
Today (17)
Last 7 days (300)
Last 30 days (1932)
Last 365 days (24228)
2026 (15836)
2025 (24084)
2024 (28185)
2023 (32068)
2022 (41577)
2021 (44281)
2020 (39884)
2019 (29793)
2018 (22395)
2017 (24055)
2016 (23351)
2015 (28879)
2014 (25236)
2013 (21014)
2012 (23136)
2011 (23387)
2010 (22767)
Location
Africa (582)
Alabama (82)
Alaska (4)
Arizona (335)
Arkansas (14)
Asia (28176)
Australia (3828)
California (13208)
Canada (3520)
China (1037)
Colorado (587)
Connecticut (474)
Delaware (295)
Europe (48945)
Florida (1926)
Georgia (413)
Hawaii (4)
Idaho (52)
Illinois (875)
India (87)
Indiana (364)
Iowa (20)
Japan (498)
Kansas (121)
Kentucky (39)
Louisiana (37)
Maine (35)
Maryland (1414)
Massachusetts (9097)
Michigan (333)
Minnesota (672)
Mississippi (5)
Missouri (104)
Montana (23)
Nebraska (22)
Nevada (151)
New Hampshire (78)
New Jersey (3071)
New Mexico (24)
New York (3235)
North Carolina (1523)
North Dakota (7)
Northern California (6637)
Ohio (358)
Oklahoma (19)
Oregon (22)
Pennsylvania (2516)
Puerto Rico (26)
Rhode Island (39)
South America (803)
South Carolina (80)
South Dakota (1)
Southern California (5368)
Tennessee (139)
Texas (2165)
United States (44065)
Utah (418)
Vermont (1)
Virginia (204)
Washington D.C. (59)
Washington State (1007)
West Virginia (3)
Wisconsin (95)
Wyoming (2)
576,683 Results for "bio path holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readouts
With a Phase 3 failure denting the rare disease drug’s prospects, AstraZeneca has little room for error as it plots a path toward its ambitious 2030 sales target.
July 22, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
May 14, 2026
·
5 min read
Press Releases
Focus on The Path Forward for Orviglance
August 20, 2026
·
3 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Press Releases
Bio-Path Holdings Provides Clinical and Operational Update
June 4, 2025
·
8 min read
Business
Bio-Path Holdings Reports First Quarter 2024 Financial Results
Bio-Path Holdings, Inc. announced its financial results for the first quarter ended March 31, 2024 and provided an update on recent corporate developments.
May 15, 2024
·
7 min read
Press Releases
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
June 9, 2025
·
3 min read
Drug Development
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Bio-Path Holdings, Inc. announced an upcoming poster presentation at the 2024 European Hematology Association Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 24, 2024
·
4 min read
Press Releases
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
August 18, 2026
·
6 min read
1 of 57,669
Next
